Showing results (501-510 of 661) with videos related to
Sort By:
Pageof 67
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2009
Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trialArnaud D Roth, Sabine Tejpar, Mauro Delorenzi, et al.Autism Research : Official Journal of the International Society for Autism Research|February 11, 2011
Contactin 4 as an autism susceptibility locusCatherine E Cottrell, Natalie Bir, Elizabeth Varga, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244Peter J Hoskin, Lisa Lowry, Alan Horwich, et al.The Journal of Biological Chemistry|January 12, 2010
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1Michelle Pacholec, John E Bleasdale, Boris Chrunyk, et al.Cancer Medicine|May 8, 2024
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trialKen Kato, Yuichiro Doki, Ian Chau, et al.Clinical Colorectal Cancer|June 22, 2019
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)Rachel P Riechelmann, Vichien Srimuninnimit, Roberto Bordonaro, et al.BMC Cancer|November 3, 2023
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 studyDo-Youn Oh, Maria Alsina Maqueda, David I Quinn, et al.Journal of Surgical Oncology|August 17, 2021
The role of surgery after prolonged primary chemotherapy for advanced oesophageal adenocarcinomaMohamed S Aboul-Enein, William Knight, Wahyu Wulaningsih, et al.Blood|September 2, 2020
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphomaPhilippe Armand, Ann Janssens, Giuseppe Gritti, et al.European Journal of Cancer (Oxford, England : 1990)|July 6, 2019
The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapyMassimiliano Salati, Francesco Caputo, David Cunningham, et al.Pageof 67